| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Director | Common Stock | 26,056 | $2,700,183 | $103.63 | 07 May 2025 | Direct |
| GILEAD SCIENCES, INC. | Director | Non-qualified Stock Option (Right to Buy) | 12,648 | $1,004,884 | $79.45 | 08 May 2024 | Direct |
| GILEAD SCIENCES, INC. | Director | Non-qualified Stock Option (Right to Buy) | 6,809 | 07 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GILD | GILEAD SCIENCES, INC. | 07 May 2025 | 2 | $0 | 4 | Director | 08 May 2025, 18:20 |
| GILD | GILEAD SCIENCES, INC. | 08 May 2024 | 2 | $0 | 4 | Director | 09 May 2024, 17:57 |
| GILD | GILEAD SCIENCES, INC. | 03 May 2023 | 2 | +$808,245 | 4 | Director | 04 May 2023, 19:10 |
| GILD | GILEAD SCIENCES, INC. | 05 May 2022 | 2 | $0 | 4 | Director | 06 May 2022, 19:04 |
| GILD | GILEAD SCIENCES, INC. | 03 May 2022 | 2 | $0 | 4 | Director | 03 May 2022, 20:21 |
| GILD | GILEAD SCIENCES INC | 12 May 2021 | 2 | $0 | 4 | Director | 14 May 2021, 16:27 |
| GILD | GILEAD SCIENCES INC | 06 May 2021 | 2 | $0 | 4 | Director | 07 May 2021, 18:59 |